Selecting a Treatment Regimen for Patients with Transplant-Eligible NDMM
October 27th 2022A panel of experts discusses whether all patients with multiple myeloma should undergo transplant, and how to select the optimal treatment regimens for the treatment of transplant-eligible newly-diagnosed multiple myeloma.
Induction Regimen Options for Patients with Transplant-Eligible NDMM
October 27th 2022Amrita Krishnan, MD, presents the case of a 63-year-old woman with transplant-eligible newly-diagnosed multiple myeloma, and Caitlin Costello, MD, describes the design and outcomes of recent trials in the transplant eligible setting.
Choosing the Appropriate Induction Regimen in Transplant-Eligible NDMM
September 15th 2022Surbhi Sidana, MD, and Caitlin Costello, MD, introduce the updated evidence regarding induction regimens for patients with transplant-eligible NDMM and how to select the appropriate induction regimen in this population.